KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BeOne Medicines (ONC) Inventory: 2017-2025

Historic Inventory for BeOne Medicines (ONC) over the last 8 years, with Sep 2025 value amounting to $531.7 million.

  • BeOne Medicines' Inventory rose 23.17% to $531.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $531.7 million, marking a year-over-year increase of 23.17%. This contributed to the annual value of $495.0 million for FY2024, which is 18.95% up from last year.
  • According to the latest figures from Q3 2025, BeOne Medicines' Inventory is $531.7 million, which was up 5.73% from $502.9 million recorded in Q2 2025.
  • Over the past 5 years, BeOne Medicines' Inventory peaked at $531.7 million during Q3 2025, and registered a low of $73.0 million during Q1 2021.
  • Over the past 3 years, BeOne Medicines' median Inventory value was $443.3 million (recorded in 2024), while the average stood at $427.1 million.
  • Data for BeOne Medicines' Inventory shows a peak YoY surged of 324.99% (in 2021) over the last 5 years.
  • Quarterly analysis of 5 years shows BeOne Medicines' Inventory stood at $242.6 million in 2021, then climbed by 16.37% to $282.3 million in 2022, then spiked by 47.38% to $416.1 million in 2023, then grew by 18.95% to $495.0 million in 2024, then rose by 23.17% to $531.7 million in 2025.
  • Its Inventory was $531.7 million in Q3 2025, compared to $502.9 million in Q2 2025 and $494.7 million in Q1 2025.